Roche opens new research center in Boston, expanding its local presence

Roche announced the opening of a new research facility in Boston, adding to its existing operations in the city.

The center will focus on early-stage drug discovery and will house several hundred scientists working on oncology and rare disease programs.

The expansion reflects Roche's strategy to strengthen its presence in key biotech hubs and to accelerate collaboration with local academic and industry partners.

The announcement was part of a broader biotech roundup that also noted the first gene‑therapy approval for Sanfilippo syndrome and a study linking a rare gene variant to higher lung‑cancer risk in non‑smokers.